ION BLUE Encyclopedia

Palmitoyl Oligopeptide

Palmitoyl oligopeptide is a lipidated peptide cosmetic ingredient, cited within a peptide blend with palmitoyl tetrapeptide-7. Evidence is from a multi-ingredient blend, so effects cannot be attributed to palmitoyl oligopeptide alone.

Evidence: Low

Reading time:1 min
Citations:1
Updated:July 11, 2026

Type

Peptide

Direct Answer

Palmitoyl oligopeptide is a lipidated peptide cosmetic ingredient, cited within a peptide blend with palmitoyl tetrapeptide-7. Evidence is from a multi-ingredient blend, so effects cannot be attributed to palmitoyl oligopeptide alone.

Summary Table

Evidence Level

Low

Key Information

Classification

Signal Peptides1 Mechanisms

Key Takeaways

  • Palmitoyl oligopeptide is a cosmetic peptide used in blends
  • Cited evidence is from a multi-ingredient blend (with palmitoyl tetrapeptide-7)
  • Effects cannot be attributed to this peptide alone

Scientific Overview

In Plain English

Palmitoyl oligopeptide is a peptide used in anti-aging skincare, usually in blends. The cited study tested it together with another peptide, so any benefit cannot be credited to this one ingredient.

Scientific Details

Palmitoyl oligopeptide is a palmitoylated peptide used in cosmetics. A study using ex vivo immunohistochemistry and in vivo human evaluation of a blend of palmitoyl oligopeptide and palmitoyl tetrapeptide-7 reported improved extracellular-matrix structure versus placebo, which the authors described as preliminary. Because it was a blend, effects cannot be attributed to palmitoyl oligopeptide alone.

How It Works

Palmitoyl oligopeptide is described in relation to dermal extracellular-matrix signaling; the cited study evaluated it within a peptide blend rather than in isolation.

Mechanism of Action

Extracellular-matrix signaling (formulation-level)

cell

A blend containing palmitoyl oligopeptide was associated with extracellular-matrix changes in ex vivo and in vivo evaluation; the individual peptide effect was not isolated.

Evidence Level

Human Evidence

In vivo human evaluation of a peptide blend reported improved extracellular-matrix structure versus placebo, described as preliminary.

Cell Evidence

Ex vivo immunohistochemistry on skin explants examined matrix-protein changes for the blend.

Limitations

Evidence is from a blend; effects cannot be attributed to palmitoyl oligopeptide alone, and the authors described findings as preliminary. The cited study is manufacturer-funded (Sederma).

Why This Grade

Graded low: the grade depends on a single cited in vitro study of an ingredient blend, funded by the manufacturer (Sederma), whose authors described the findings as preliminary. No human study is cited, and effects cannot be attributed to palmitoyl oligopeptide alone.

References

  1. Evaluation of dermal extracellular matrix and epidermal-dermal junction modifications using cosmetic peptides. Journal of Cosmetic Dermatology.Cell / In Vitrodoi:10.1111/jocd.12135

Alternative Names

  • Pal-oligopeptide
  • palmitoyl tripeptide complex

Claim Boundaries

ION BLUE is an educational research aggregator. This content summarizes published scientific literature. It is not medically reviewed, is not medical advice, and is not a recommendation to use any substance. Several peptides discussed are research chemicals not approved for human use. Consult a licensed healthcare provider. Cited evidence is from a peptide blend; this entry does not attribute effects to this peptide alone and is not a recommendation to use it.

This page summarizes published research and is for informational purposes only; it is not medical advice.